CDNA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart

caredx inc (CDNA) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CAREDX INC (CDNA)
\

Related News

No related news articles were found.

caredx inc (CDNA) Related Businessweek News

No Related Businessweek News Found

caredx inc (CDNA) Details

CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide. The company develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell-free DNA test initially used for kidney transplant patients. The company also develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and organs. It sells Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence-specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables speed and precision in HLA typing at a low to intermediate resolution for samples that require a fast turn-around-time and uses real-time polymerase chain reaction methodology; and TruSight HLA, a high resolution solution that uses next generation sequencing methodology. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina for the development, commercialization, and distribution of next generation sequencing product line for use in transplantation diagnostic testing. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

227 Employees
Last Reported Date: 03/6/19
Founded in 1998

caredx inc (CDNA) Top Compensated Officers

CEO & Director
Total Annual Compensation: $1.2M
President & Chief Business Officer
Total Annual Compensation: $450.9K
Chief Financial Officer
Total Annual Compensation: $650.5K
Chief Medical Officer
Total Annual Compensation: $567.7K
Compensation as of Fiscal Year 2018.
caredx inc
CareDx, Inc Appoints Grace Colón, Ph.D. as A Class I Director

CareDx Inc. appointed Grace Colón, Ph.D. as a Class I director of the Company. Dr. Colón’s service on the Board commenced on July 1, 2019. Dr. Colón will serve as a member of the Science and Technology Committee of the Board. Previously, she served on the boards of Paradigm Diagnostics and PerceptiMed. She was formerly a partner at New Science Ventures and held various leadership roles at Intrexon Corporation, Gilead Sciences and Affymetrix. Earlier in her career, she was an engagement manager with McKinsey & Co. Dr. Colón received her B.S. in chemical engineering from the University of Pennsylvania and a Ph.D. in chemical engineering from the Massachusetts Institute of Technology.

CareDx, Inc Presents at Piper Jaffray Diagnostics & Tools Day, Jun-26-2019

CareDx, Inc Presents at Piper Jaffray Diagnostics & Tools Day, Jun-26-2019 . Venue: Boston, Massachusetts, United States. Speakers: Michael Bell, Chief Financial Officer, Peter Maag, CEO & Director.

CareDx, Inc Presents at Raymond James Life Sciences and MedTech Conference, Jun-18-2019 10:55 AM

CareDx, Inc Presents at Raymond James Life Sciences and MedTech Conference, Jun-18-2019 10:55 AM. Venue: Lotte New York Palace hotel, New York, New York, United States. Speakers: Michael Bell, Chief Financial Officer, Peter Maag, CEO & Director.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CDNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CDNA.
View Industry Companies
 

Industry Analysis

CDNA

Industry Average

Valuation CDNA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.9x
Price/Book 13.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CAREDX INC, please visit www.caredxinc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.